poisar

Stocks · News reference

Solesence Q2 Sales $15.332M Down From $20.359M YoY

BenzingaBenzinga Newsdesk

Solesence (NASDAQ:SLSN) reported $15.332 million in sales this quarter. This is a 24.69 percent decrease over sales of $20.359 million the same period last year.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — SOLESENCE, INC. (SLSN)

    Filed: 2026-08-21 AccNo: 0001171843-26-005702 Size: 188 KB Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review Item 9.01: Financial Statements and Exhibits